 |
 |
|||||||||||||||||||||||
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
|
|
|
 |
 |
|
|||||
 |
|
|||||||||||||||||||||||
 |
|
|||||||||||||||||||||||
|
We understand both the challenges and the opportunities facing both public and private small- and mid-cap companies. We help our clients effectively manage such opportunities using not only our solid background in finance, science and media, but by leveraging our strong relationships with key healthcare bankers, analysts, portfolio managers, venture capitalists and reporters. Our knowledgeable and experienced team specializes in developing and executing strategies for media visibility, investor relations, business development, patient advocacy outreach and clinical trial recruitment. These strategies meet the needs of both private and public biotechnology companies seeking to increase their visibility in the investment community and the media. For more information about our life sciences practice, please contact Gregory Q. Tiberend, EVP & COO, at 212-827-0020 or gtiberend@rlcinc.com RLC LIFE SCIENCES GROUP is a sponsor of the annual Sachs Associates NORTH AMERICA FORUM FOR INVESTING & PARTNERING IN BIOTECH AND MEDTECH, held each March in Boston.
|
